Jecheon, Chungcheonbuk, 27159, Korea (The Republic of) | Sterile Drug Manufacturer Procedures designed to prevent microbiological contamination of drug products purporting to be sterile do not include adequate validation of the sterilization process.
Inspection Record
Huons Co., Ltd — FDA 483 Findings
Inspectors Eileen A. Liu · Steven A. BrettlerThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Laboratory records do not include complete data derived from all tests, examinations, and assay necessary to assure compliance with established specifications and standards.
Written records of investigations into unexplained discrepancies do not always include the conclusions and follow-up.
Batch production and control records do not include complete information relating to the production and control of each batch.
Aseptic processing areas are deficient regarding the system for cleaning and disinfecting the equipment to produce aseptic conditions.
There is a failure to thoroughly review any unexplained discrepancy or the failure of a batch or any of its components to meet any of its specifications whether or not the batch has been already distributed.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Orean Personal Care Ltd2026-02-20 · US FDASimilar to finding 6 There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch or any of its components to meet any of its specifications…
- Jubilant HollisterStier LLC2026-06-17 · US FDASimilar to finding 3 Written records of investigations into unexplained discrepancies do not always include the conclusions and follow-up.
- Zhejiang Huahai Pharmaceutical Co., Ltd.2026-04-24 · US FDASimilar to finding 2 Laboratory records do not include complete data derived from all tests, examinations, and assay necessary to assure compliance with established specifications…
- Phoenix Innovative Healthcare Manufactures Private Limited2024-09-27 · US FDASimilar to finding 6 There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch or any of its components to meet any of its specifications…
- Glenmark Pharmaceuticals Inc USA2022-05-19 · US FDASimilar to finding 6 There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch or any of its components to meet any of its specifications…
A record as of the US FDA document published on 2026-11-12. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.